WPA
ALXN

West Paces Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

West Paces Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6
Closed -$1.1K – 650
2021
Q2 		$1.1K Buy
+6
New +$1.03K ﹤0.01% 595
2019
Q4 		– Sell
-2
Closed -$196 – 506
2019
Q3 		$196 Buy
+2
New +$225 ﹤0.01% 483
2019
Q1 		– Sell
-10
Closed -$974 – 489
2018
Q4 		$974 Hold
10
– – ﹤0.01% 468
2018
Q3 		$1.39K Hold
10
– – ﹤0.01% 458
2018
Q2 		$1.24K Buy
+10
New +$1.17K ﹤0.01% 466
2017
Q3 		– Sell
-23
Closed -$2.8K – 517
2017
Q2 		$2.8K Hold
23
– – ﹤0.01% 430
2017
Q1 		$2.79K Sell
23
-34
-60% -$4.38K ﹤0.01% 429
2016
Q4 		$6.97K Buy
+57
New +$6.97K 0.01% 381

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return